Key result
Heparin-coated pulmonary artery catheter insertion is associated with a ~48-second increase in introducer ACT.
Why the study?
The effect of heparin-coated pulmonary artery catheters (HPACs) on activated coagulation time (ACT) drawn through a non-heparin-coated introducer sheath required investigation.
Does insertion of a heparin-coated pulmonary artery catheter increase activated coagulation time drawn through a non-heparin-coated introducer sheath in patients undergoing surgical procedures requiring cardiopulmonary bypass?
Observational (n=63)
No
Does insertion of a heparin-coated pulmonary artery catheter increase activated coagulation time drawn through a non-heparin-coated introducer sheath in patients undergoing surgical procedures requiring cardiopulmonary bypass?
Blood obtained from an introducer sheath with a heparin-coated pulmonary artery catheter in situ yields a spuriously elevated activated coagulation time by 48 seconds, necessitating that baseline ACT be drawn prior to catheter placement.
OBJECTIVE To investigate the effect of heparin-coated pulmonary artery catheters (HPACs) on activated coagulation time (ACT) drawn through a non-heparin-coated introducer sheath. DESIGN A prospective, observational study. SETTING University teaching hospital. PARTICIPANTS Patients scheduled for surgical procedures requiring cardiopulmonary bypass. INTERVENTIONS With institutional review board approval, 63 patients without prior coagulopathy undergoing procedures requiring cardiopulmonary bypass were studied. Jugular venous and radial arterial ACTs were measured before and immediately after insertion of an HPAC. Additional measurements were obtained 1 hour later and 4 minutes after completion of protamine infusion. MEASUREMENTS AND MAIN RESULTS The ACT drawn from the introducer after placement of an HPAC was 48 seconds greater than the ACT drawn before the HPAC was placed (p < 0.0001). This difference was still present 1 hour later but not after the administration of protamine or in blood drawn at any time from another site. Baseline ACTs drawn from radial arterial catheters, kept patent using a heparin flush system, resulted in elevated measurements, despite withdrawing seven times the deadspace before taking a sample. CONCLUSIONS Blood obtained from an introducer with an HPAC in situ provides a spuriously high ACT. ACTs drawn from catheters kept patent using heparin flush also result in prolonged measurements. Baseline ACT measurement from an introducer should be obtained before placement of the HPAC.
No takes yet. Share an insight, caveat, or question.
Haering et al. (2000) conducted an observational in Cardiac surgical procedures requiring cardiopulmonary bypass (n=63). Heparin-coated pulmonary artery catheter (HPAC) placement vs. Pre-placement baseline measurement from the non-heparin-coated introducer sheath was evaluated on Activated coagulation time (ACT) drawn from a non-heparin-coated introducer sheath (MD 48 seconds, p=<0.0001). Heparin-coated pulmonary artery catheter placement increased activated coagulation time drawn from the introducer by 48 seconds compared to pre-placement baseline (p < 0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: